Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
received Twinrix dose 1 on 04-JUL-2024, dose 2 on 07-AUG-2024 but she has yet to receive dose 3; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (Received 1st dose of Twinrix vaccine on 04-JUL-2024.) and Twinrix (Received 2nd dose of Twinrix vaccine on 07-AUG-2024.). On an unknown date, the patient did not receive the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: received Twinrix dose 1 on 04-JUL-2024, dose 2 on 07-AUG-2024 but she has yet to receive dose 3). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-JAN-2025 The reporter is the husband of a patient. The patient received Twinrix dose 1 on 04 July 2024 and dose 2 on 07 August 2024 but she had yet to receive dose 3 which led to incomplete course of vaccination. The reporter had mentioned at the end of the conversation that a pharmacy technician was a certified immunizer though he was not practicing currently. Did not consent to follow-up.